4//SEC Filing
BOBULSKY SUSAN 4
Accession 0001209191-20-052780
CIK 0001478320other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 8:00 PM ET
Size
8.8 KB
Accession
0001209191-20-052780
Insider Transaction Report
Form 4
BOBULSKY SUSAN
Chief Commercial Officer, MRD
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-09-29−10,000→ 55,000 totalExercise: $1.98Exp: 2024-10-13→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2020-09-29$1.98/sh+10,000$19,800→ 10,000 total - Sale
Common Stock
2020-09-29$50.00/sh−10,000$500,000→ 0 total
Footnotes (2)
- [F1]These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2019.
- [F2]All options are fully exercisable.
Documents
Issuer
Adaptive Biotechnologies Corp
CIK 0001478320
Entity typeother
Related Parties
1- filerCIK 0001820885
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 8:00 PM ET
- Size
- 8.8 KB